$3.83
2.95% today
Nasdaq, Apr 04, 07:04 pm CET
ISIN
US60853G1067
Symbol
MOLN
Sector
Industry

Molecular Partners AG - ADR Target price 2025 - Analyst rating & recommendation

Molecular Partners AG - ADR Classifications & Recommendation:

Buy
71%
Hold
29%

Molecular Partners AG - ADR Price Target

Target Price $9.49
Price $3.72
Potential
Number of Estimates 7
7 Analysts have issued a price target Molecular Partners AG - ADR 2026 . The average Molecular Partners AG - ADR target price is $9.49. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 5 Analysts recommend Molecular Partners AG - ADR to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Molecular Partners AG - ADR stock has an average upside potential 2026 of . Most analysts recommend the Molecular Partners AG - ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 5.64 0.57
27.97% 89.98%
EBITDA Margin -1,184.75% -12,325.03%
42.04% 940.30%
Net Margin -1,176.38% -10,314.39%
19.00% 776.79%

4 Analysts have issued a sales forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR sales estimate is

$565k
Unlock
. This is
89.96% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.3m 59.86%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.6m 27.97%
2025
$565k 89.98%
Unlock
2026
$6.2m 999.33%
Unlock
2027
$35.8m 475.76%
Unlock
2028
$28.3m 21.00%
Unlock
2029
$100m 254.58%
Unlock

3 Analysts have issued an Molecular Partners AG - ADR EBITDA forecast 2025. The average Molecular Partners AG - ADR EBITDA estimate is

$-69.6m
Unlock
. This is
4.23% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-66.6m 0.27%
Unlock
, the lowest is
$-75.3m 12.73%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-66.8m 2.31%
2025
$-69.6m 4.22%
Unlock
2026
$-65.1m 6.46%
Unlock
2027
$-37.7m 42.15%
Unlock
2028
$-101m 167.02%
Unlock
2029
$-72.6m 27.89%
Unlock

EBITDA Margin

2024 -1,184.75% 42.04%
2025
-12,325.03% 940.30%
Unlock
2026
-1,048.74% 91.49%
Unlock
2027
-105.38% 89.95%
Unlock
2028
-356.19% 238.01%
Unlock
2029
-72.43% 79.67%
Unlock

1 Analyst has issued a net profit forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR net profit estimate is

$-58.3m
Unlock
. This is
12.65% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-58.3m 12.65%
Unlock
, the lowest is
$-58.3m 12.65%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-66.3m 14.29%
2025
$-58.3m 12.16%
Unlock
2026
$-37.5m 35.72%
Unlock
2027
$45.8m 222.24%
Unlock

Net Margin

2024 -1,176.38% 19.00%
2025
-10,314.39% 776.79%
Unlock
2026
-603.16% 94.15%
Unlock
2027
128.04% 121.23%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share $ -1.80 -1.58
14.29% 12.22%
P/E negative
EV/Sales negative

1 Analysts have issued a Molecular Partners AG - ADR forecast for earnings per share. The average Molecular Partners AG - ADR EPS is

$-1.58
Unlock
. This is
12.71% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.58 12.71%
Unlock
, the lowest is
$-1.58 12.71%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.80 14.29%
2025
$-1.58 12.22%
Unlock
2026
$-1.02 35.44%
Unlock
2027
$1.24 221.57%
Unlock

P/E ratio

Current -2.05 2.50%
2025
-2.35 14.63%
Unlock
2026
-3.66 55.74%
Unlock
2027
2.99 181.69%
Unlock

Based on analysts' sales estimates for 2025, the Molecular Partners AG - ADR stock is valued at an EV/Sales of

-44.28
Unlock
and an P/S ratio of
242.79
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -4.44 56.56%
2025
-44.28 897.36%
Unlock
2026
-4.03 90.90%
Unlock
2027
-0.70 82.63%
Unlock
2028
-0.89 26.60%
Unlock
2029
-0.25 71.80%
Unlock

P/S ratio

Current 24.37 37.73%
2025
242.79 896.45%
Unlock
2026
22.09 90.90%
Unlock
2027
3.84 82.63%
Unlock
2028
4.86 26.59%
Unlock
2029
1.37 71.80%
Unlock

Current Molecular Partners AG - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
TD COWEN
Locked
Locked
Locked Oct 31 2024
Analyst Rating Date
Locked
TD COWEN:
Locked
Locked
Oct 31 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today